Phone (USA) +1 212-348-5610
Whatsapp: +1 516-336-9307
WeChat: chembuyersguide
Chemical Search
 


























CordenPharma International




Country: USA

CordenPharma International
c/o 2075 55th Street
Boulder, CO 80301

Corden Pharma International GmbH
Otto-Hahn-Strasse
68723 Plankstadt
Germany


Phone: +41 79 645 2746
E-Mail:E-Mail this Supplier

Contact: Matthieu Giraud, PhD

https://www.cordenpharma.com/contact-us/

https://www.cordenpharma.com/lipid-catalog/

CordenPharma is your full-service CDMO in the manufacturing of innovative APIs, Lipid Excipients and Drug Products. Through a network of facilities organized under five technology platforms - Peptides - Lipids & Carbohydrates - Injectables - Highly Potent & Oncology - Small Molecules - CordenPharma experts translate complex ideas into high-value products.

Peptides

  • World-class development & manufacturing services seamlessly supporting all clinical & commercial stages
  • Fully-integrated solution from drug substance to fill & finish drug product
  • Unique expertise in both SPPS & LPPS technology for efficient Peptide manufacturing
  • Full access to batch record process (you own the IP) and knowledge sharing guaranteed
  • Largest equipment available to leverage sizeable up and downstream processes for your APIs
  • Solvent recycling concepts with a green manufacturing approach

Lipids & Carbohydrates

  • Specialized Lipids offering including custom & standard lipids (Glycero-Phospholipids, Sphingolipids, Phosphocholine, Pegylated, and Cationic Lipids)
  • Lipids for support of mRNA vaccine production including Phosphocholine, Pegylated, Cationic Lipids and highly pure plant-based CP BotaniChol® (cholesterol)
  • Fully-integrated service offering > from APIs to finished dosage and pharmaceutical services (clinical trial kits preparation, randomization and logistics)
  • Backward integration of key starting materials to secure supply chain
  • Manufacturing of carbohydrate-based APIs, vaccines, delivery systems, and conjugates (with lipids and/or peptides for receptor targeting)

Sterile Injectables

  • Wide & balanced range of injectable services (including combining injectable drugs & devices as combination products)
  • Aseptic & Terminal Sterilization Fill & Finish Technologies for Pre-Filled Syringes (PFS), ampoules, liquid and lyophilized vials, supporting a wide range of filling volumes
  • Substantial Drug Product regulatory and filing experience globally (EMEA, FDA, PMDA)
  • Packaging / labeling Clinical trial drug kit management (logistics, track & trace, documentation)
  • LNP Formulation of Drug Products

Highly Potent & Oncology

  • API Development & Commercial Manufacturing (SafeBridge Category 4, OEL =50 ng/m3)
    • High Containment for Cytotoxic & Cytostatic APIs
    • Low Volume (Clinical Batches > Commercial Manufacturing)
    • Quality by Design (QbD) Development Approach
    • Highly Potent Small Molecules & Peptides (Solid & Solution-Phase)
    • Highly Potent Purification by Chromatography
  • Drug Product Development & Manufacturing

    • Oral Solid Dose
    • Highly Potent Drug Products
    • Full Development Capabilities (from 100g to commercial-scale)
    • Quality by Design (QbD) Development Approach
    • Coated & Uncoated Tablets
    • Hard Gelatine Capsules
    • Pediatric Formulations
    • Packaging: Blisters & Bottles
    • Serialization & 2D Data Matrix Coding

Small Molecules

  • Integrated network of cGMP facilities across Europe and US
  • 1,200 m3 of volumetric capacity in 20 L - 28,000 L reactors with various materials of construction
  • Clinical (Phase I-III) and ongoing commercial supply to multiple markets around the world (including US, Europe and Japan)
  • Kilo to Multi-ton production volumes per annum
  • Process development capabilities (including flow / continuous manufacturing
  • All sites FDA & EMEA approved facilities with successful regulatory & customer audits
  • Strong EHS programs in place at sites

Product List: 49

PON:Page:


 


2-Lyso-phospholipids

P-LYSO-PC
CAS:17364-16-8
LP-R4-078
S-LYSO-PC
CAS:19420-57-6
LP-R4-083


Cationic & Ionizable Lipids

C12-200
CAS:1220890-25-4
LP-04-425
DLIN-KC2-DMA
CAS:119-0197-97-7
LP-04-242
DODMA
CAS:104162-47-2
LP-R4-110
DOTAP CL
CAS:132172-61-3
LP-R4-117
DOTMA
CAS:104162-48-3
LP-04-496


Cholesterol & Derivatives

BHEM-Chol
CAS:624742-83-2
LP-04-492
BotaniChol® (Cholesterol from plant origin)
CAS:57-88-5
LP-C4-477  
CHEMS
CAS:1510-21-0
LP-04-247
Cholesterol-PEG
CAS:205743-50-6
LP-04-493
DC-CHOLESTEROL
CAS:137056-72-5
LP-04-491
MOCHOL
CAS:452323-21-6
LP-04-248
SCS (HIGH PURITY >98%)
CAS:2864-50-8
LP-R4-091


MPEGylated (Methoxypolyethyleneglycol-) Phospholipids

mPEG-2000-DMPE, Na
CAS:384835-59-0
LP-R4-123
mPEG-2000-DPPE, Na
CAS:205494-72-0
LP-R4-080
mPEG-2000-DSPE, Na
CAS:147867-65-0
LP-R4-039
mPEG-5000-DMPE, Na
CAS:384835-59-0
LP-R4-077
mPEG-5000-DPPE, Na
CAS:205494-72-0
LP-R4-075
mPEG-5000-DSPE, Na
CAS:147867-65-0
LP-R4-092
mPEG-750-DSPE, Na
CAS:147867-65-0
LP-R4-087


Phosphatidic Acids

DLPA, NA
CAS:108321-06-8
LP-R4-121
DMPA, NA
CAS:80724-31-8
LP-R4-024
DPPA, NA
CAS:169051-60-9
LP-R4-025
DSPA, NA
CAS:108321-18-2
LP-R4-026


Phosphocholines

DLPC
CAS:18194-25-7
LP-R4-101
DMPC
CAS:18194-24-6
LP-R4-058
DOPC
CAS:4235-95-4
LP-R4-070
DPEPC, CHLORIDE
CAS:328250-18-6
LP-R4-095
DPEPC, TRIFLATE
CAS:474945-32-9
LP-R4-102
DPPC
CAS:63-89-8
LP-R4-057
DSPC
CAS:816-94-4
LP-R4-076


Phosphoethanolamines

1,2-POPE
CAS:26662-94-2
LP-R4-266
1,3-DPPE
CAS:67303-93-9
LP-R4-167
DLPE
CAS:42436-56-6
LP-R4-064
DMPE
CAS:998-07-2
LP-R4-018
DOPE
CAS:4004-05-01
LP-R4-069
DPPE
CAS:923-61-5
LP-R4-019
DPYPE
CAS:201036-16-0
LP-R4-147
DSPE
CAS:1069-79-0
LP-R4-020


Phosphoglycerols

DLPG, NA
CAS:73548-69-3
LP-R4-079
DMPG, NA
CAS:200880-40-6
LP-R4- 015
DPPG, NA
CAS:200880-41-7
LP-R4-016
DSPG, NA
CAS:124011-52-5
LP-R4-017
POPG, NA
CAS:268550-95-4
LP-R4-124
POPG, NH4
CAS:267228-70-6
LP-R4-074


Phospholipids

1,3-POPE
CAS:884324-34-9
LP-R4-163
POPC
CAS:26853-31-6
LP-R4-031
SMPC
CAS:20664-02-2
LP-R4-152